Skip to content

Nkarta, Inc.

NKTX Nasdaq SEC CIK 1787400

Follow Nkarta Weekly email: filings, results, news

News

1 story filed under Nkarta

Nkarta: 'Hold' NKX019 Discontinuation For R/R NHL And Pivot To Autoimmune Disorders

Markets 21 d ago

Profile

Headquarters: SOUTH SAN FRANCISCO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 1 story clustered from the RSS aggregator